MedTrace Logo

Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)

NCT05794698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 827

Last updated 2024-09-03

No results posted yet for this study

Summary

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1014). The goal of this clinical trial is to confirm the concordance rate between intra-operative frozen section pathological diagnosis and post-operative paraffin embedded pathological diagnosis, and use this result to guide surgical treatment for early stage (cT1N0M0) lung adenocarcinomas.

Conditions

Interventions

PROCEDURE

Surgical resection

Surgical resection of lung adenocarcinoma. Wedge resection, segmentectomy or lobectomy will be performed according to each patients' condition.

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    collaborator OTHER

  • Tongji Hospital, Wuhan, Hubei Province, China

    collaborator UNKNOWN

  • Sixth People's Hospital, Shanghai, China

    collaborator UNKNOWN

  • Ningbo Clinical Pathological Diagnostic Center, Ningbo, Zhejiang Province, China

    collaborator UNKNOWN

  • Dongfang Hospital Affiliated to Tongji University, Shanghai, China

    collaborator UNKNOWN

  • Minhang Hospital Affiliated to Fudan University, Shanghai, China

    collaborator UNKNOWN

  • People's Hospital of Jiangdu, Yangzhou, Jiangsu Province, China

    collaborator UNKNOWN

  • Liaocheng People's Second Hospital, Liaocheng, Shandong Province, China

    collaborator UNKNOWN

  • Guanxian People's Hospital, Liaocheng, Shandong Province, China

    collaborator UNKNOWN

  • Zhoupu Hospital, Pudong New Area, Shanghai, China

    collaborator OTHER

  • Fudan University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-06-30
Completion
2024-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794698 on ClinicalTrials.gov